NKTR
Nektar Therapeutics
NASDAQ: NKTR · HEALTHCARE · BIOTECHNOLOGY
$85.04
+2.21% today
Updated 2026-04-30
Market cap
$2.76B
P/E ratio
—
P/S ratio
50.03x
EPS (TTM)
$-9.73
Dividend yield
—
52W range
$8 – $109
Volume
1.1M
Nektar Therapeutics (NKTR) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $858.55M | $768.18M | $725.10M | $560.54M | $575.52M | $521.23M | $606.55M | $497.79M | $434.53M | $441.62M | $502.06M | $568.87M | $508.87M | $2.15B | $1.98B | $1.54B | $1.12B | $710.60M | $398.03M | $303.85M |
| Cash & equivalents | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Current assets | $519.84M | $535.04M | $523.28M | $406.22M | $413.67M | $353.98M | $276.71M | $314.63M | $257.88M | $288.20M | $350.05M | $426.25M | $326.82M | $1.44B | $1.42B | $1.14B | $795.58M | $545.97M | $330.70M | $261.29M |
| Total liabilities | $531.74M | $541.12M | $510.66M | $370.38M | $473.15M | $430.56M | $408.74M | $450.77M | $524.43M | $405.29M | $495.63M | $480.75M | $421.04M | $432.60M | $571.97M | $461.47M | $437.68M | $343.96M | $267.05M | $243.11M |
| Current liabilities | $69.59M | $165.31M | $98.09M | $68.37M | $153.02M | $64.11M | $275.53M | $78.54M | $98.22M | $64.05M | $61.25M | $72.22M | $56.16M | $82.00M | $353.89M | $115.78M | $85.20M | $68.20M | $51.27M | $61.40M |
| Long-term debt | $439.30M | $334.76M | $336.63M | $235.30M | $233.75M | $231.97M | $14.58M | $125.00M | $125.00M | $125.00M | $242.12M | $243.46M | $245.21M | $246.95M | — | — | — | — | — | — |
| Shareholder equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Retained earnings | $-902.23M | $-1.06B | $-1.09B | $-1.12B | $-1.23B | $-1.26B | $-1.40B | $-1.57B | $-1.73B | $-1.79B | $-1.87B | $-2.02B | $-2.12B | $-1.42B | $-1.86B | $-2.31B | $-2.83B | $-3.20B | $-3.48B | $-3.60B |
| Accounts receivable | $8.21M | $47.15M | $21.64M | $11.16M | $4.80M | $25.10M | $4.94M | $5.80M | $2.23M | $3.61M | $19.95M | $15.68M | $5.01M | $43.21M | $36.80M | $38.89M | $22.49M | $8.40M | $2.25M | $1.61M |
| Inventory | $18.63M | $14.66M | $12.19M | $9.32M | $6.47M | $7.27M | $12.66M | $18.27M | $13.45M | $12.95M | $11.35M | $11.11M | $10.73M | $11.38M | $12.66M | $15.29M | $15.80M | $19.20M | $16.10M | $0.00 |
| Goodwill | $78.43M | $78.43M | $78.43M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $76.50M | $0.00 | — |